There's a lot in this interview, especially if you can get through the technical stuff. I note that Shane Storey, the Wilsons Advisory Senior Research Analyst conducting the interview, has two undergrad degrees in Molecular Biology and Chem Eng, a Ph D in BioChem Eng and an MBA in Corp Fin! - a lot of education there....and he seems to be supportive of ANP's case.
A couple more quotes from Prof Voit:
the MRI data was ''surprising' and ''particularly precious'. the ph 2a data to date 'looks good, the spaghetti data was smooth and consistent'
At the 41 min mark he said that "I think the picture looks good" and "this works"
Could ATL 1102 be used for ambulatory patients? "Absolutely! Use this as early as possible - before the boys are aged 4 years...it will be definitely beneficial''
ANP Price at posting:
8.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)